Concord Drugs Ltd vs Vasundhara Rasayans Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Concord Drugs Ltd is ₹ 85.13 as of 30 Apr 15:30 . The P/E Ratio of Concord Drugs Ltd changed from 15.9 on March 2022 to 91.4 on March 2025 . This represents a CAGR of 54.84% over 4 yearsThe P/E Ratio of Vasundhara Rasayans Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of Concord Drugs Ltd changed from ₹ 25.36 crore on March 2022 to ₹ 31.08 crore on March 2025 . This represents a CAGR of 5.22% over 4 yearsThe Market Cap of Vasundhara Rasayans Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The revenue of Concord Drugs Ltd for the Dec '25 is ₹ 16.99 crore as compare to the Sep '25 revenue of ₹ 10.28 crore. This represent the growth of 65.27% The revenue of Vasundhara Rasayans Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Concord Drugs Ltd for the Dec '25 is ₹ 0.94 crore as compare to the Sep '25 ebitda of ₹ 1.1 crore. This represent the decline of -14.55% The ebitda of Vasundhara Rasayans Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Concord Drugs Ltd changed from ₹ 0.03 crore to ₹ 0.22 crore over 7 quarters. This represents a CAGR of 212.22% The net profit of Vasundhara Rasayans Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Concord Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vasundhara Rasayans Ltd changed from 16.22 % on March 2021 to 14.96 % on March 2025 . This represents a CAGR of -1.60% over 5 years .

About Concord Drugs Ltd

Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved.
The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad.
State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing.

About Vasundhara Rasayans Ltd

Vasundhara Rasayans Limited was incorporated in March, 1987.
The Company is the leading manufacturer and exporter of Antacids therapeutic category of Active Pharmaceutical Ingredients with annual capacity of about 1500 MT of powder or its equivalent products.
It started its operation in year 1990 with an Antacid API facility offering product in paste, powder and micronised grade of powder. The plant is located on National Highway between Mumbai and Goa in an Industrial Zone called Mahad which is about 170 KMS from Mumbai and about 125 KMS from the NSICT /JNPT Ports Mumbai.
In addition to the API manufacturing Vasundhara is also having an API intermediate plant to handle organic products with its state of the art specialised Friedel Craft reaction facility. The manufacturing area is maintained as per GMP standards.

FAQs for the comparison of Concord Drugs Ltd and Vasundhara Rasayans Ltd

Which company has a larger market capitalization, Concord Drugs Ltd or Vasundhara Rasayans Ltd?

Market cap of Concord Drugs Ltd is 112 Cr while Market cap of Vasundhara Rasayans Ltd is 41 Cr

What are the key factors driving the stock performance of Concord Drugs Ltd and Vasundhara Rasayans Ltd?

The stock performance of Concord Drugs Ltd and Vasundhara Rasayans Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Concord Drugs Ltd and Vasundhara Rasayans Ltd?

As of May 4, 2026, the Concord Drugs Ltd stock price is INR ₹85.13. On the other hand, Vasundhara Rasayans Ltd stock price is INR ₹129.3.

How do dividend payouts of Concord Drugs Ltd and Vasundhara Rasayans Ltd compare?

To compare the dividend payouts of Concord Drugs Ltd and Vasundhara Rasayans Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.